Convergent Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Convergent Therapeutics, Inc. — Developing next-generation targeted combination therapies to advance the care of...
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Teon Therapeutics Inc.
Teon is a clinical company targeting metabolic signaling pathways and pioneering the devel...
Redwood City, United Stat...
ARTBIO
Channeling Energy. Changing Lives.
Cambridge, United States
Track all Convergent Therapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Pepkon
Pioneering breakthrough peptides for treating challenging cancers with precision and hope.
Paris, France
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
San Diego, United States
Prokarium
LIVING CURES
London, United Kingdom
Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer t...
Cambridge, United States
Exelixis
Exelixis works on discovering, developing, and commercializing therapies for the treatment...
Alameda, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
MILAGEN, INC.
Advancing Health Care Through Diagnostics
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
About Convergent Therapeutics, Inc.
Developing next-generation targeted combination therapies to advance the care of cancer patients.
Development of targeted radiotherapies, Alpha radioantibody innovation, Clinical trials for cancer treatments
Cancer patients, Oncologists, Healthcare institutions
Clinical-stage Biotechnology, Cancer Treatment, Targeted Combination Therapies, Radiopharmaceutical Therapies, Prostate Cancer, Dual-targeted Radionuclide Therapy, Targeting Agents, Monoclonal Antibodies, Ligand Targeting, PSMA-targeting, Internalized Payload Delivery, Alpha Particle Emitters, Radioisotope Therapy, Oncological Research, Issued Patents
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Convergent Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Convergent Therapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 23 Nov 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.